首页> 外文OA文献 >A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

【2h】

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

机译：患有盆腔浆液癌（P53签名）的候选前体及其在BRCA突变中妇女卵巢和输卵管的患病率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ann K. Folkins; Elke A. Jarboe; Aasia Saleemuddin; Yonghee Lee; Michael J. Callahan; Ronny Drapkin; Judy E. Garber; Michael G. Muto; Shelley Tworoger; Christopher P. Crum;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. [J] . Folkins AK, Jarboe EA, Saleemuddin A, Gynecologic Oncology: An International Journal . 2008,第2期

机译：骨盆浆液性癌（p53标记）及其在患有BRCA突变的女性的卵巢和输卵管中的流行率的候选先兆。
2. The impact of tissue block sampling on the detection of p53 signatures in fallopian tubes from women with BRCA 1 or 2 mutations (BRCA|[plus]|) and controls [J] . Karishma K Mehra, Martin C Chang, Ann K Folkins, Modern Pathology . 2011,第1期

机译：组织块取样对患有BRCA 1或2突变（BRCA | + |）和对照的女性输卵管中p53信号的检测的影响
3. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1|[sol]|2 mutation carriers [J] . Patricia A Shaw, Marjan Rouzbahman, Ellen S Pizer, Modern Pathology . 2009,第9期

机译：BRCA1 | [sol] | 2突变携带者输卵管上皮中的浆液性浆液癌前体
4. Mutation Frequency in BRCA1 and BRCA2 Genes Among Women with Breast Cancer in Kabardino-Balkaria [C] . Bittueva M., Hashhozheva D., Dzhambetova P., International Conference on Health and Well-Being in Modern Society . 2019

机译：BRCA1和BRCA2基因在Kabardino-Balkaria的乳腺癌中BRCA2基因的突变频率
5. Dolo?anje Mutacij v Genih BRCA1/2 Iz citolo?kega Materiala Pri Raku jaj?nikov, Jajcevodov in Primarnem Peritonealnem Seroznem Karcinomu =BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer [D] . Gornjec, Andreja. 2020

机译：从自我癌症中确定基因Krca1 / 2中的突变吗？
6. A Candidate Precursor to Pelvic Serous Cancer (p53 Signature) and Its Prevalence in Ovaries and Fallopian Tubes from Women with Heterozygous BRCA Mutations [O] . Ann K. Folkins, Elke A. Jarboe, Aasia Saleemuddin, -1

机译：患有杂合BRCA突变的女性盆腔浆液性癌（p53签名）的候选先兆及其在卵巢和输卵管中的患病率
7. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers [O] . Patricia A Shaw, Marjan Rouzbahman, Ellen S Pizer, 2009

机译：BRCA1 / 2突变载体输卵管上皮中候选浆液癌前体
8. Development of a Conditional Transgenic Mouse Model to Test the Fallopian Tube Origin of Serous Ovarian Cancer [R] . Shepherd, T. 2009

机译：开发一种条件转基因小鼠模型来检测浆液性卵巢癌的输卵管起源

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

著录项

引文网络

相似文献

相关主题

期刊订阅